Lista de obras -

Added Value of Deep Sequencing Relative to Population Sequencing in Heavily Pre-Treated HIV-1-Infected Subjects ⬇️

artículo científico publicado el 13 de mayo de 2011

Alternation of antiretroviral drug regimens for HIV infection. Efficacy, safety and tolerability at week 96 of the Swatch Study

artículo científico publicado en 2004

Antiretroviral simplification with darunavir/ritonavir monotherapy in routine clinical practice: safety, effectiveness, and impact on lipid profile

artículo científico publicado en 2012

Antiretroviral therapy suppressed participants with low CD4+ T-cell counts segregate according to opposite immunological phenotypes

artículo científico publicado en 2016

Balances: a New Perspective for Microbiome Analysis

artículo científico publicado en 2018

Clinical course impacts early kinetics,magnitude, and amplitude of SARS-CoV-2 neutralizing antibodies beyond 1 year after infection

artículo científico publicado en 2022

Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control study

article

Compromised immunologic recovery in treatment-experienced patients with HIV infection receiving both tenofovir disoproxil fumarate and didanosine in the TORO studies

artículo científico publicado en 2005

Connection Domain Mutations in HIV-1 Reverse Transcriptase Do Not Impact Etravirine Susceptibility and Virologic Responses to Etravirine-Containing Regimens ⬇️

artículo científico publicado el 4 de abril de 2011

Contribution of immunological and virological factors to extremely severe primary HIV type 1 infection

artículo científico publicado en 2009

Decreased phenotypic susceptibility to etravirine in patients with predicted genotypic sensitivity

artículo científico publicado en 2014

Deep molecular characterization of HIV-1 dynamics under suppressive HAART

artículo científico publicado en 2011

Dolutegravir-based maintenance monotherapy versus dual therapy with lamivudine: a planned 24 week analysis of the DOLAM randomized clinical trial

artículo científico publicado en 2018

Dynamic escape of pre-existing raltegravir-resistant HIV-1 from raltegravir selection pressure

artículo científico publicado en 2010

Effect of an induction period of pegylated interferon-α2a and ribavirin on early virological response in HIV-HCV-coinfected patients: results from the CORAL-2 study

artículo científico publicado en 2011

Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study

artículo científico publicado en 2011

Effectiveness of a Treatment Switch to Nevirapine plus Tenofovir and Emtricitabine (or Lamivudine) in Adults with HIV-1 Suppressed Viremia

artículo científico publicado en 2015

European recommendations for the clinical use of HIV drug resistance testing: 2011 update

artículo científico publicado el 1 de abril de 2011

Global Dispersal Pattern of HIV Type 1 Subtype CRF01_AE: A Genetic Trace of Human Mobility Related to Heterosexual Sexual Activities Centralized in Southeast Asia

artículo científico publicado en 2014

Gut Microbiota Linked to Sexual Preference and HIV Infection.

artículo científico publicado en 2016

Gut microbiome comparability of fresh-frozen versus stabilized-frozen samples from hospitalized patients using 16S rRNA gene and shotgun metagenomic sequencing

artículo científico publicado en 2019

HIV-1 infection in subjects older than 70: a multicenter cross-sectional assessment in Catalonia, Spain

artículo científico publicado en 2009

HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics

artículo científico publicado en 2013

HIV-1 tropism testing in subjects achieving undetectable HIV-1 RNA: diagnostic accuracy, viral evolution and compartmentalization

artículo científico publicado en 2013

HLA class I protective alleles in an HIV-1-infected subject homozygous for CCR5-Δ32/Δ32.

artículo científico publicado en 2012

Highly pathogenic adapted HIV-1 strains limit host immunity and dictate rapid disease progression

artículo científico publicado en 2014

Incidence of post-acute COVID-19 symptoms across healthcare settings in seven countries: an international retrospective cohort study using routinely-collected data

artículo científico publicado en 2024

Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe

artículo científico publicado en 2014

Increased peripheral proinflammatory cytokines in HIV-1-infected patients with prolonged viral suppression suffering from high psychological stress

artículo científico publicado en 2009

Limited cross-border infections in patients newly diagnosed with HIV in Europe

artículo científico publicado en 2013

Long-Term Safety and Efficacy of Nevirapine-Based Approaches in HIV Type 1-Infected Patients

article

Low nadir CD4+ T-cell counts predict gut dysbiosis in HIV-1 infection

article

Low-abundance drug-resistant HIV-1 variants in antiretroviral drug-naïve individuals: A systematic review of detection methods, prevalence, and clinical impact

artículo científico publicado en 2019

Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case-control study using centralized ultrasensitive 454 pyrosequencing

artículo científico publicado en 2014

No detection of the NS5B S282T mutation in treatment-naïve genotype 1 HCV/HIV-1 coinfected patients using deep sequencing

artículo científico publicado en 2013

Patterns of transmitted HIV drug resistance in Europe vary by risk group

artículo científico publicado en 2014

Performance comparison of next generation sequencing analysis pipelines for HIV-1 drug resistance testing

scientific article published on 31 January 2020

Postpartum antiretroviral drug resistance in HIV-1-infected women receiving pregnancy-limited antiretroviral therapy

artículo científico publicado en 2010

Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failure

artículo científico publicado en 2010

Primary resistance to integrase strand transfer inhibitors in patients infected with diverse HIV-1 subtypes in sub-Saharan Africa.

artículo científico publicado en 2018

Quality of life, emotional status, and adherence of HIV-1-infected patients treated with efavirenz versus protease inhibitor-containing regimens

artículo científico publicado en 2002

Quantitative deep sequencing reveals dynamic HIV-1 escape and large population shifts during CCR5 antagonist therapy in vivo

artículo científico publicado en 2009

Quebrada Jaguay: Early South American Maritime Adaptations ⬇️

artículo científico publicado el 18 de septiembre de 1998

Randomised study to assess the efficacy and safety of once-daily etravirine-based regimen as a switching strategy in HIV-infected patients receiving a protease inhibitor-containing regimen. Etraswitch study

artículo científico publicado en 2014

Randomized, crossover, double-blind, placebo-controlled trial to assess the lipid lowering effect of co-formulated TDF/FTC.

artículo científico publicado en 2014

Relationship between minority nonnucleoside reverse transcriptase inhibitor resistance mutations, adherence, and the risk of virologic failure

artículo científico publicado en 2012

Reversal of HIV-1-associated osteoporosis with once-weekly alendronate

artículo científico publicado en 2005

Reversal of atherogenic lipoprotein profile in HIV-1 infected patients with lipodystrophy after replacing protease inhibitors by nevirapine

artículo científico publicado en 2002

Richer gut microbiota with distinct metabolic profile in HIV infected Elite Controllers

artículo científico publicado en 2017

Role of structured treatment interruption before a 5-drug salvage antiretroviral regimen: the Retrogene Study.

artículo científico publicado en 2003

Routine screening of anal cytology in HIV-infected subjects and the impact on invasive anal cancer. A prospective cohort study

artículo científico publicado en 2019

Short Communication: Efficacy and Safety of Treatment Simplification to Lopinavir/Ritonavir or Darunavir/Ritonavir Monotherapy: A Randomized Clinical Trial

artículo científico publicado en 2016

Single oral dose of maraviroc does not prevent ex-vivo HIV infection of rectal mucosa in HIV-1 negative human volunteers

artículo científico publicado en 2015

Stable HIV-1 integrase diversity during initial HIV-1 RNA decay suggests complete blockade of plasma HIV-1 replication by effective raltegravir-containing salvage therapy

artículo científico publicado en 2013

Superinfection with drug-resistant HIV is rare and does not contribute substantially to therapy failure in a large European cohort

artículo científico publicado en 2013

Switching the third drug of antiretroviral therapy to maraviroc in aviraemic subjects: a pilot, prospective, randomized clinical trial

artículo científico publicado en 2013

The burden of post-acute COVID-19 symptoms in a multinational network cohort analysis

artículo científico publicado en 2023

The evolving landscape of HIV drug resistance diagnostics for expanding testing in resource-limited settings

artículo científico publicado en 2017

The global spread of HIV-1 subtype B epidemic

artículo científico publicado en 2016

The lipid-lowering effect of tenofovir/emtricitabine: a randomized, crossover, double-blind, placebo-controlled trial

artículo científico publicado en 2015

Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe

artículo científico publicado en 2015

Trends and predictors of transmitted drug resistance (TDR) and clusters with TDR in a local Belgian HIV-1 epidemic

artículo científico publicado en 2014

Triple-class virologic failure in HIV-infected patients undergoing antiretroviral therapy for up to 10 years

artículo científico publicado en 2010

Unexpected CD4 cell count decline in patients receiving didanosine and tenofovir-based regimens despite undetectable viral load

artículo científico publicado en 2004

Vicriviroc Resistance Decay and Relative Replicative Fitness in HIV-1 Clinical Isolates under Sequential Drug Selection Pressures ⬇️

artículo científico publicado el 4 de abril de 2012

Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression

artículo científico publicado en 2002

Lista de obras de

Added Value of Deep Sequencing Relative to Population Sequencing in Heavily Pre-Treated HIV-1-Infected Subjects ⬇️

Alternation of antiretroviral drug regimens for HIV infection. Efficacy, safety and tolerability at week 96 of the Swatch Study

Antiretroviral simplification with darunavir/ritonavir monotherapy in routine clinical practice: safety, effectiveness, and impact on lipid profile

Antiretroviral therapy suppressed participants with low CD4+ T-cell counts segregate according to opposite immunological phenotypes

Balances: a New Perspective for Microbiome Analysis

Clinical course impacts early kinetics,magnitude, and amplitude of SARS-CoV-2 neutralizing antibodies beyond 1 year after infection

Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control study

Compromised immunologic recovery in treatment-experienced patients with HIV infection receiving both tenofovir disoproxil fumarate and didanosine in the TORO studies

Connection Domain Mutations in HIV-1 Reverse Transcriptase Do Not Impact Etravirine Susceptibility and Virologic Responses to Etravirine-Containing Regimens ⬇️

Contribution of immunological and virological factors to extremely severe primary HIV type 1 infection

Decreased phenotypic susceptibility to etravirine in patients with predicted genotypic sensitivity

Deep molecular characterization of HIV-1 dynamics under suppressive HAART

Dolutegravir-based maintenance monotherapy versus dual therapy with lamivudine: a planned 24 week analysis of the DOLAM randomized clinical trial

Dynamic escape of pre-existing raltegravir-resistant HIV-1 from raltegravir selection pressure

Effect of an induction period of pegylated interferon-α2a and ribavirin on early virological response in HIV-HCV-coinfected patients: results from the CORAL-2 study

Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study

Effectiveness of a Treatment Switch to Nevirapine plus Tenofovir and Emtricitabine (or Lamivudine) in Adults with HIV-1 Suppressed Viremia

European recommendations for the clinical use of HIV drug resistance testing: 2011 update

Global Dispersal Pattern of HIV Type 1 Subtype CRF01_AE: A Genetic Trace of Human Mobility Related to Heterosexual Sexual Activities Centralized in Southeast Asia

Gut Microbiota Linked to Sexual Preference and HIV Infection.

Gut microbiome comparability of fresh-frozen versus stabilized-frozen samples from hospitalized patients using 16S rRNA gene and shotgun metagenomic sequencing

HIV-1 infection in subjects older than 70: a multicenter cross-sectional assessment in Catalonia, Spain

HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics

HIV-1 tropism testing in subjects achieving undetectable HIV-1 RNA: diagnostic accuracy, viral evolution and compartmentalization

HLA class I protective alleles in an HIV-1-infected subject homozygous for CCR5-Δ32/Δ32.

Highly pathogenic adapted HIV-1 strains limit host immunity and dictate rapid disease progression

Incidence of post-acute COVID-19 symptoms across healthcare settings in seven countries: an international retrospective cohort study using routinely-collected data

Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe

Increased peripheral proinflammatory cytokines in HIV-1-infected patients with prolonged viral suppression suffering from high psychological stress

Limited cross-border infections in patients newly diagnosed with HIV in Europe

Long-Term Safety and Efficacy of Nevirapine-Based Approaches in HIV Type 1-Infected Patients

Low nadir CD4+ T-cell counts predict gut dysbiosis in HIV-1 infection

Low-abundance drug-resistant HIV-1 variants in antiretroviral drug-naïve individuals: A systematic review of detection methods, prevalence, and clinical impact

Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case-control study using centralized ultrasensitive 454 pyrosequencing

No detection of the NS5B S282T mutation in treatment-naïve genotype 1 HCV/HIV-1 coinfected patients using deep sequencing

Patterns of transmitted HIV drug resistance in Europe vary by risk group

Performance comparison of next generation sequencing analysis pipelines for HIV-1 drug resistance testing

Postpartum antiretroviral drug resistance in HIV-1-infected women receiving pregnancy-limited antiretroviral therapy

Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failure

Primary resistance to integrase strand transfer inhibitors in patients infected with diverse HIV-1 subtypes in sub-Saharan Africa.

Quality of life, emotional status, and adherence of HIV-1-infected patients treated with efavirenz versus protease inhibitor-containing regimens

Quantitative deep sequencing reveals dynamic HIV-1 escape and large population shifts during CCR5 antagonist therapy in vivo

Quebrada Jaguay: Early South American Maritime Adaptations ⬇️

Randomised study to assess the efficacy and safety of once-daily etravirine-based regimen as a switching strategy in HIV-infected patients receiving a protease inhibitor-containing regimen. Etraswitch study

Randomized, crossover, double-blind, placebo-controlled trial to assess the lipid lowering effect of co-formulated TDF/FTC.

Relationship between minority nonnucleoside reverse transcriptase inhibitor resistance mutations, adherence, and the risk of virologic failure

Reversal of HIV-1-associated osteoporosis with once-weekly alendronate

Reversal of atherogenic lipoprotein profile in HIV-1 infected patients with lipodystrophy after replacing protease inhibitors by nevirapine

Richer gut microbiota with distinct metabolic profile in HIV infected Elite Controllers

Role of structured treatment interruption before a 5-drug salvage antiretroviral regimen: the Retrogene Study.

Routine screening of anal cytology in HIV-infected subjects and the impact on invasive anal cancer. A prospective cohort study

Short Communication: Efficacy and Safety of Treatment Simplification to Lopinavir/Ritonavir or Darunavir/Ritonavir Monotherapy: A Randomized Clinical Trial

Single oral dose of maraviroc does not prevent ex-vivo HIV infection of rectal mucosa in HIV-1 negative human volunteers

Stable HIV-1 integrase diversity during initial HIV-1 RNA decay suggests complete blockade of plasma HIV-1 replication by effective raltegravir-containing salvage therapy

Superinfection with drug-resistant HIV is rare and does not contribute substantially to therapy failure in a large European cohort

Switching the third drug of antiretroviral therapy to maraviroc in aviraemic subjects: a pilot, prospective, randomized clinical trial

The burden of post-acute COVID-19 symptoms in a multinational network cohort analysis

The evolving landscape of HIV drug resistance diagnostics for expanding testing in resource-limited settings

The global spread of HIV-1 subtype B epidemic

The lipid-lowering effect of tenofovir/emtricitabine: a randomized, crossover, double-blind, placebo-controlled trial

Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe

Trends and predictors of transmitted drug resistance (TDR) and clusters with TDR in a local Belgian HIV-1 epidemic

Triple-class virologic failure in HIV-infected patients undergoing antiretroviral therapy for up to 10 years

Unexpected CD4 cell count decline in patients receiving didanosine and tenofovir-based regimens despite undetectable viral load

Vicriviroc Resistance Decay and Relative Replicative Fitness in HIV-1 Clinical Isolates under Sequential Drug Selection Pressures ⬇️

Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression